Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 41 of 95, showing 5 Applications out of 474 total, starting on record 201, ending on 205

# Protocol No Study Title Investigator(s) & Site(s)

201.

ECCT/20/06/02   EMPACTA Covid19 Study
    A RANDOMIZED, DOUBLE-BLIND, Placebo-Controlled, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TOCILIZUMAB IN HOSPITALIZED PATIENTS WITH COVID‑19 PNEUMONIA   
Principal Investigator(s)
1. Reena Shah
Site(s) in Kenya
AgaKhan University Hospital Nairobi
 
View

202.

ECCT/20/02/03   LNG 1.5mg for pericoital use
    A Study on the Feasibility and Acceptability of Pericoital Levonorgestrel 1.5mg    
Principal Investigator(s)
1. Anne Mwihaki Macharia
Site(s) in Kenya
1. Nairobi County (Nairobi City county)
2. Kiambu County (Kiambu county)
 
View

203.

ECCT/10/03/03   High-Dose Fluconazole Treatment in AIDS-Associated CM
    A5225/HiFLAC: A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
 
View

204.

ECCT/11/02/01   Compare the Efficacy and Safety of Gentian Violet to that of Nystatin
    A5265 - A Phase III, Open-Label, Randomized, Assessment-Blinded Clinical Trial to Compare the Safety and Efficacy of Topical Gentian Violet to that of Nystatin Oral Suspension for the Treatment of Oropharyngeal Candidiasis in HIV-1 Infected Participants in Non-U.S. Settings   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Walter Reed Project (Kericho county)
 
View

205.

ECCT/12/07/03   PK Substudy of A5263 and A5264
    A5278 - Pharmacology Substudies of A5263 and A5264   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Walter Reed Project (Kericho county)
 
View